Inhibition of macrophage adhesion activity by 9trans,11trans-conjugated linoleic acid

Journal of Nutritional Biochemistry

Volumn 21, Issue 6, 2010, Pages 490-497

  Lee, Yunkyoung ^a   Vanden Heuvel, John P ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

9E,11E CLA; Adhesion molecules; Endothelial cells; Macrophages

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CONJUGATED LINOLEIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; VASCULAR CELL ADHESION MOLECULE 1; 9,11-LINOLEIC ACID; ANTIINFLAMMATORY AGENT; CYTOKINE; MTOR PROTEIN, HUMAN; MTOR PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; DRUG EFFECTS; METABOLISM; MOUSE; UMBILICAL VEIN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINOLEIC ACIDS, CONJUGATED; MACROPHAGES; MICE; MODELS, BIOLOGICAL; PROTEIN-SERINE-THREONINE KINASES; UMBILICAL VEINS; PHOSPHATIDYLINOSITOL 3-KINASES; TOR SERINE-THREONINE KINASES;

ANIMALIA;

EID: 77952879645     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.02.005     Document Type: Article

References (48)

1. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
2. Weissberg P.L. Atherogenesis: current understanding of the causes of atheroma. Heart 2000, 83:247-252.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
4. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104:503-516.
5. Pariza M.W., Ha Y.L. Conjugated dienoic derivatives of linoleic acid: a new class of anticarcinogens. Med Oncol Tumor Pharmacother 1990, 7:169-171.
6. Pariza M.W., Ha Y.L. Newly recognized anticarcinogenic fatty acids. Basic Life Sci 1990, 52:167-170.
7. Wahle K.W., Heys S.D., Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res 2004, 43:553-587.
8. Nicolosi R.J., Rogers E.J., Kritchevsky D., Scimeca J.A., Huth P.J. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997, 22:266-277.
9. Kritchevsky D., Tepper S.A., Wright S., Czarnecki S.K., Wilson T.A., Nicolosi R.J. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids 2004, 39:611-616.
10. Song H.J., Sneddon A.A., Heys S.D., Wahle K.W. Induction of apoptosis and inhibition of NF-kappaB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate 2006, 66:839-846.
11. Bhattacharya A., Banu J., Rahman M., Causey J., Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 2006.
12. Munday J.S., Thompson K.G., James K.A. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 1999, 81:251-255.
13. Chen B.Q., Yang Y.M., Wang Q., Gao Y.H., Liu J.R., Zhang J.S., et al. Effects of c9,t11-conjugated linoleic acid on adhesion of human gastric carcinoma cell line SGC-7901. World J Gastroenterol 2004, 10:1392-1396.
14. Nugent A.P., Roche H.M., Noone E.J., Long A., Kelleher D.K., Gibney M.J. The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur J Clin Nutr 2005, 59:742-750.
15. Schleser S., Ringseis R., Eder K. Conjugated linoleic acids have no effect on TNFalpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosclerosis 2006, 186:337-344.
16. Lee Y., Thompson J.T., de Lera A.R., Vanden Heuvel J.P. Isomer-specific effects of conjugated linoleic acid on gene expression in RAW 264.7. J Nutr Biochem 2008, Epub ahead of press. 10.1016/j.jnutbio.2008.07.013.
17. Isoda K., Ohsuzu F. The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. J Atheroscler Thromb 2006, 13:21-30.
18. Kusuhara M., Isoda K., Ohsuzu F. Interleukin-1 and occlusive arterial diseases. Cardiovasc Hematol Agents Med Chem 2006, 4:229-235.
19. Francis S.E., Camp N.J., Dewberry R.M., Gunn J., Syrris P., Carter N.D., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999, 99:861-866.
20. Yu Y., Correll P.H., Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 2002, 1581:89-99.
21. Coleman J.D., Prabhu K.S., Thompson J.T., Reddy P.S., Peters J.M., Peterson B.R., et al. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Free Radic Biol Med 2007, 42:1155-1164.
22. Lemaire S., Lizard G., Monier S., Miguet C., Gueldry S., Volot F., et al. Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett 1998, 440:434-439.
23. Vaporciyan A.A., Jones M.L., Ward P.A. Rapid analysis of leukocyte-endothelial adhesion. J Immunol Methods 1993, 159:93-100.
24. Sakamoto K., Ito Y., Mori T., Sugimura K. Interaction of human lactoferrin with cell adhesion molecules through RGD motif elucidated by lactoferrin-binding epitopes. J Biol Chem 2006, 281:24472-24478.
25. Kim J.D., Liu L., Guo W., Meydani M. Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. J Nutr Biochem 2006, 17:165-176.
26. Gotsch U., Jager U., Dominis M., Vestweber D. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes Commun 1994, 2:7-14.
27. Weller A., Isenmann S., Vestweber D. Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J Biol Chem 1992, 267:15176-15183.
28. Isoda K., Shiigai M., Ishigami N., Matsuki T., Horai R., Nishikawa K., et al. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation 2003, 108:516-518.
29. Lee Y., Thompson J.T., Vanden Heuvel J.P. Increased expression of the endogenous anti-inflammatory factor IL-1 receptor antagonist (IL-1Ra) by 9E,11E-conjugated linoleic acid. J Nutr 2009, [submitted].
30. Wang Y.W., Jones P.J. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004, 28:941-955.
31. Nagao K., Yanagita T. Conjugated fatty acids in food and their health benefits. J Biosci Bioeng 2005, 100:152-157.
32. Lee K.N., Kritchevsky D., Pariza M.W. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 1994, 108:19-25.
33. Toomey S., Harhen B., Roche H.M., Fitzgerald D., Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2006, 187:40-49.
34. Benito P., Nelson G.J., Kelley D.S., Bartolini G., Schmidt P.C., Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 2001, 36:229-236.
35. Benito P., Nelson G.J., Kelley D.S., Bartolini G., Schmidt P.C., Simon V. The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 2001, 36:221-227.
36. Krieglstein C.F., Granger D.N. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001, 14:44S-54S.
37. Huo Y., Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand 2001, 173:35-43.
38. Leeuwenberg J.F., Smeets E.F., Neefjes J.J., Shaffer M.A., Cinek T., Jeunhomme T.M., et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992, 77:543-549.
39. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
40. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997, 186:1757-1762.
41. Inoue S., Egashira K., Ni W., Kitamoto S., Usui M., Otani K., et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 2002, 106:2700-2706.
42. O'Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., Fishbein D., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993, 92:945-951.
43. Dewberry R., Holden H., Crossman D., Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:2394-2400.
44. Gottsater A., Forsblad J., Matzsch T., Persson K., Ljungcrantz I., Ohlsson K., et al. Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies. J Intern Med 2002, 251:61-68.
45. Peng H.B., Spiecker M., Liao J.K. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998, 161:1970-1976.
46. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 1997, 272:30969-30974.
47. Kuno K., Okada Y., Kawashima H., Nakamura H., Miyasaka M., Ohno H., et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000, 478:241-245.
48. Torres-Collado A.X., Kisiel W., Iruela-Arispe M.L., Rodriguez-Manzaneque J.C. ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2. J Biol Chem 2006, 281:17827-17837.